Gossamer Bio News - GOSS

Company Name	Stock Ticker Symbol	Market	Type
Gossamer Bio Inc	GOSS	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	-0.002	-0.24%	0.818	20:00:00

Open Price	Low Price	High Price	Close Price	Prev Close
0.82	0.7901	0.859	0.806	0.82

more quote information »

Recent News

Date	Time	Source	Heading
3/12/2024	07:31	BW	Gossamer Bio Announces Appointment of Steven D. Nathan,..
3/05/2024	07:37	EDGAR2	Form S-8 - Securities to be offered to employees in employee..
3/05/2024	07:32	EDGAR2	Form 10-K - Annual report [Section 13 and 15(d), not S-K..
3/05/2024	07:31	EDGAR2	Form 8-K - Current report
3/05/2024	07:31	BW	Gossamer Bio Announces Fourth Quarter and Full-Year 2023..
3/04/2024	16:02	EDGAR2	Form 8-K - Current report
1/08/2024	16:01	BW	Gossamer Bio Announces Inducement Grant Under Nasdaq Listing..
1/04/2024	17:11	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
1/04/2024	17:04	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
1/04/2024	17:02	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
12/13/2023	16:01	BW	Gossamer Bio to Host Webcast to Discuss Latest Seralutinib..
12/05/2023	17:12	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
12/05/2023	17:09	EDGAR2	Form 3 - Initial statement of beneficial ownership of..
12/05/2023	16:01	BW	Gossamer Bio Announces Inducement Grant Under Nasdaq Listing..
12/05/2023	07:01	BW	Gossamer Bio Appoints Bob Smith as Chief Commercial Officer
11/29/2023	16:01	EDGAR2	Form 8-K - Current report
11/29/2023	07:01	BW	Gossamer Bio Announces Appointment of John Quisel, J.D.,..
11/27/2023	16:01	EDGAR2	Form 8-K - Current report
11/22/2023	19:07	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
11/22/2023	19:07	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
11/22/2023	19:07	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
11/17/2023	16:01	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
11/14/2023	18:24	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
11/09/2023	07:31	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/09/2023	07:31	EDGAR2	Form 8-K - Current report
11/09/2023	07:31	BW	Gossamer Bio Announces Third Quarter 2023 Financial Results..
10/20/2023	16:01	EDGAR2	Form 8-K - Current report
10/03/2023	16:08	BW	Gossamer Bio Announces Addition of Rainer Zimmermann, MD, as..
9/07/2023	17:00	EDGAR2	Form 8-K - Current report
9/07/2023	07:44	BW	Gossamer Bio to Present Results of TORREY FRI Sub-Study at..
8/29/2023	00:15	EDGAR2	Form EFFECT - Notice of Effectiveness
8/28/2023	16:29	EDGAR2	Form 424B3 - Prospectus [Rule 424(b)(3)]
8/21/2023	16:01	EDGAR2	Form DEL AM - Delaying amendment
8/18/2023	08:41	EDGAR2	Form S-3 - Registration statement under Securities Act of..
8/18/2023	08:38	EDGAR2	Form RW - Registration Withdrawal Request
8/17/2023	16:01	EDGAR2	Form S-3ASR - Automatic shelf registration statement of..
8/08/2023	16:03	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/08/2023	16:01	EDGAR2	Form 8-K - Current report
8/08/2023	16:01	BW	Gossamer Bio Announces Second Quarter 2023 Financial Results..
7/28/2023	15:46	EDGAR2	Form SC 13D - General statement of acquisition of beneficial..
7/26/2023	16:03	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
7/24/2023	16:16	BW	Gossamer Bio to Hold Conference Call with PAH Experts to..
7/20/2023	16:01	EDGAR2	Form 8-K - Current report
7/20/2023	07:56	BW	Gossamer Bio Announces $212 Million Private Placement..
7/20/2023	07:50	EDGAR2	Form 8-K - Current report
5/18/2023	07:05	BW	Gossamer Bio Announces TORREY Data to be Featured at..
5/09/2023	16:01	BW	Gossamer Bio Announces First Quarter 2023 Financial Results..